5-178994769-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000843.4(GRM6):​c.176A>C​(p.Gln59Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.589 in 1,369,858 control chromosomes in the GnomAD database, including 240,162 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Synonymous variant affecting the same amino acid position (i.e. Q59Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.57 ( 24597 hom., cov: 34)
Exomes 𝑓: 0.59 ( 215565 hom. )

Consequence

GRM6
NM_000843.4 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6O:1

Conservation

PhyloP100: -0.195

Publications

22 publications found
Variant links:
Genes affected
GRM6 (HGNC:4598): (glutamate metabotropic receptor 6) L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Mutations in this gene result in congenital stationary night blindness type 1B. [provided by RefSeq, May 2018]
GRM6 Gene-Disease associations (from GenCC):
  • congenital stationary night blindness 1B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • GRM6-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • congenital stationary night blindness
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.1140935E-5).
BP6
Variant 5-178994769-T-G is Benign according to our data. Variant chr5-178994769-T-G is described in ClinVar as Benign. ClinVar VariationId is 93438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.594 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000843.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM6
NM_000843.4
MANE Select
c.176A>Cp.Gln59Pro
missense
Exon 2 of 11NP_000834.2O15303

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM6
ENST00000517717.3
TSL:5 MANE Select
c.176A>Cp.Gln59Pro
missense
Exon 2 of 11ENSP00000430767.1O15303
GRM6
ENST00000231188.9
TSL:2
c.176A>Cp.Gln59Pro
missense
Exon 1 of 10ENSP00000231188.5O15303
GRM6
ENST00000650031.1
c.176A>Cp.Gln59Pro
missense
Exon 3 of 12ENSP00000497110.1O15303

Frequencies

GnomAD3 genomes
AF:
0.571
AC:
85484
AN:
149760
Hom.:
24568
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.533
Gnomad AMI
AF:
0.347
Gnomad AMR
AF:
0.562
Gnomad ASJ
AF:
0.510
Gnomad EAS
AF:
0.575
Gnomad SAS
AF:
0.500
Gnomad FIN
AF:
0.638
Gnomad MID
AF:
0.497
Gnomad NFE
AF:
0.599
Gnomad OTH
AF:
0.533
GnomAD2 exomes
AF:
0.550
AC:
37270
AN:
67784
AF XY:
0.539
show subpopulations
Gnomad AFR exome
AF:
0.538
Gnomad AMR exome
AF:
0.584
Gnomad ASJ exome
AF:
0.503
Gnomad EAS exome
AF:
0.546
Gnomad FIN exome
AF:
0.627
Gnomad NFE exome
AF:
0.584
Gnomad OTH exome
AF:
0.552
GnomAD4 exome
AF:
0.591
AC:
720965
AN:
1219992
Hom.:
215565
Cov.:
41
AF XY:
0.586
AC XY:
351108
AN XY:
599334
show subpopulations
African (AFR)
AF:
0.528
AC:
13273
AN:
25142
American (AMR)
AF:
0.573
AC:
12583
AN:
21942
Ashkenazi Jewish (ASJ)
AF:
0.495
AC:
9980
AN:
20160
East Asian (EAS)
AF:
0.545
AC:
13900
AN:
25496
South Asian (SAS)
AF:
0.450
AC:
26539
AN:
58974
European-Finnish (FIN)
AF:
0.626
AC:
17999
AN:
28762
Middle Eastern (MID)
AF:
0.438
AC:
1517
AN:
3464
European-Non Finnish (NFE)
AF:
0.605
AC:
597334
AN:
987550
Other (OTH)
AF:
0.574
AC:
27840
AN:
48502
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
14668
29336
44005
58673
73341
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17662
35324
52986
70648
88310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.571
AC:
85561
AN:
149866
Hom.:
24597
Cov.:
34
AF XY:
0.572
AC XY:
41803
AN XY:
73122
show subpopulations
African (AFR)
AF:
0.533
AC:
21998
AN:
41260
American (AMR)
AF:
0.563
AC:
8479
AN:
15056
Ashkenazi Jewish (ASJ)
AF:
0.510
AC:
1755
AN:
3438
East Asian (EAS)
AF:
0.574
AC:
2925
AN:
5092
South Asian (SAS)
AF:
0.501
AC:
2418
AN:
4828
European-Finnish (FIN)
AF:
0.638
AC:
6217
AN:
9750
Middle Eastern (MID)
AF:
0.479
AC:
140
AN:
292
European-Non Finnish (NFE)
AF:
0.599
AC:
40191
AN:
67152
Other (OTH)
AF:
0.537
AC:
1123
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
2002
4003
6005
8006
10008
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
726
1452
2178
2904
3630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.579
Hom.:
17041
Bravo
AF:
0.567
ESP6500AA
AF:
0.606
AC:
1561
ESP6500EA
AF:
0.652
AC:
3170
ExAC
AF:
0.439
AC:
17229
Asia WGS
AF:
0.554
AC:
1767
AN:
3188

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
not provided (3)
-
-
1
Congenital stationary night blindness 1B (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.057
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
9.4
DANN
Benign
0.72
DEOGEN2
Benign
0.080
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.038
N
LIST_S2
Benign
0.47
T
MetaRNN
Benign
0.000021
T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
-0.81
N
PhyloP100
-0.20
PrimateAI
Pathogenic
0.80
T
PROVEAN
Benign
-0.52
N
REVEL
Benign
0.14
Sift
Benign
0.92
T
Sift4G
Benign
0.57
T
Polyphen
0.0
B
Vest4
0.060
MPC
1.5
ClinPred
0.0032
T
GERP RS
-2.4
PromoterAI
0.018
Neutral
Varity_R
0.11
gMVP
0.38
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2645329; hg19: chr5-178421770; COSMIC: COSV51442230; COSMIC: COSV51442230; API